58
Views
7
CrossRef citations to date
0
Altmetric
Review

Safety of verteporfin for treatment of subfoveal choroidal neovascular membranes associated with age-related macular degeneration

&
Pages 345-361 | Published online: 23 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Waseem M Al-Zamil & Sanaa A Yassin. (2017) Recent developments in age-related macular degeneration: a review. Clinical Interventions in Aging 12, pages 1313-1330.
Read now

Articles from other publishers (6)

. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 396 405 .
Peter van Hoogevest, Mathew Leigh & Alfred Fahr. 2013. Drug Delivery Strategies for Poorly Water-Soluble Drugs. Drug Delivery Strategies for Poorly Water-Soluble Drugs 37 66 .
Francesco Parmeggiani, Donato Gemmati, Ciro Costagliola, Francesco Semeraro, Paolo Perri, Sergio D’Angelo, Mario R. Romano, Katia De Nadai, Adolfo Sebastiani & Carlo Incorvaia. (2012) Genetic Predictors of Response to Photodynamic Therapy. Molecular Diagnosis & Therapy 15:4, pages 195-210.
Crossref
Reecha Sachdeva, Hajir Dadgostar, Peter K. Kaiser, Jonathan E. Sears & Arun D. Singh. (2010) Verteporfin photodynamic therapy of six eyes with retinal capillary haemangioma. Acta Ophthalmologica 88:8.
Crossref
Alan F. Cruess, Gergana Zlateva, Andreas M. Pleil & Barbara Wirostko. (2009) Photodynamic therapy with verteporfin in age-related macular degeneration: a systematic review of efficacy, safety, treatment modifications and pharmacoeconomic properties. Acta Ophthalmologica 87:2, pages 118-132.
Crossref
B.C.P. Polak. 2008. A worldwide yearly survey of new data and trends in adverse drug reactions and interactions. A worldwide yearly survey of new data and trends in adverse drug reactions and interactions 544 550 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.